Triple Negative Breast Cancer Market Outlook 2025–2035: Innovations, Challenges, and Global Trends

Business

Introduction Triple Negative Breast Cancer (TNBC) is an aggressive subtype of breast cancer characterized by the absence of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2). This lack of receptors renders conventional hormone therapies and HER2-targeted treatments ineffective, posing signific

Read More
Page 774 of 1025